AI-disruption muddle-through, deep undervaluation post β-fix · +81.4% MoS
Market pricing catastrophic bear; β-pinned DCF prices muddle-throughLevered β pinned to 0.93 (5Y regression triangulated) collapses WACC to 4.79% vs prior 7.57% under industry re-lever. Intrinsic per share lands at €29.36 against market €5.47. Even with 4pp Y10 margin compression and terminal growth capped at EUR risk-free 2.4%, the explicit Y1-10 FCFFs (~€0.8B → €1.3B revenue, 30%+ FCF margin) carry the case. P(undervalued) = 100.0% across 1000 MC iterations.
Software (System & Application)US 34% · DE 28% · WE/APAC tail100% free float since Sep 2025MC σ €6.40/shGov haircut 0%FCF yield ~23%What it sells, where it sells
Operating segments
FY2025 single-segment IFRS reporting. Two sub-businesses inside: Enterprise (Mercedes-AMG F1 ref customer, 1.4M cumulative AI sessions, 620K endpoints) growing +8% cc ARR; SMB (legacy remote-support) shrinking −3% cc on strategic SKU pruning. The bull/bear divergence reduces to how fast Enterprise becomes the majority of revenue.
Country mix (revenue-weighted CRP input)
Revenue-weighted mix (medium confidence — TMV doesn't report country splits beyond DACH/Americas/APAC). US 34% + DACH-heavy keeps blended CRP modest (0.35%); broadly low-risk geographies for software cash flows.
Background — five things to know before the case
Context the share price doesn't carry on its face. Skim this once and the bull / bear bullets below stop reading as inside baseball.
TeamViewer SE (TMV.DE, Frankfurt-listed) is a German enterprise software firm — remote-access, remote-support, and Autonomous Endpoint Management (AEM) via the TeamViewer ONE platform. Founded 2005, IPO'd Sept 2019 (Permira-backed). FY2025 revenue €747M (+11% pro-forma over FY2024 €671M, helped by the 1E acquisition's first full year). FY2025 EBIT margin 33.87%; Q1 2026 adj. EBITDA 45.3%; FCF margin 30%+. Net debt €560M; deleveraging path 3.2x → 2.6x → targeted 2.3x.
The defining 2024-2025 events: (1) $720M acquisition of 1E (Jan 2025) bringing Digital Employee Experience (DEX) telemetry and the AEM platform thesis; (2) Permira's complete exit (Sept 2025, final 12.46M shares at €9.20) leaving 100% free float; (3) the stock crater from €13.55 high (May 2025) to €4.60 low (Feb 2026) on AI-disruption fears; (4) management/board insider buying at €6 in Oct 2025; (5) FY2026 guide 0-3% cc reflecting 1E integration churn and SMB pricing actions, with medium-term ambition of mid-to-high single-digit growth. 2-3 analysts cover; PT range €5 (Barclays/Goldman bear) to €8.21 (avg) to DZ Bank €7 / RBC Buy bull.
Where we diverge from the sector
Each row asks: if we'd used the sector median for this one assumption instead of our override, how much would the share price change? Negative = our override is more conservative (worth less); positive = more aggressive (worth more). Skim down the rightmost column to see which bets are doing the work.
The story & the five claims
The 10-year story this DCF is built on, plus the five anchor claims that translate the story into model inputs.
The 10-year story
TMV is two businesses stacked. The legacy remote-support core (~70% of revenue, SMB-heavy) is in slow secular decline as AI-native tools bundle the use case (SMB ARR −3% cc, customer count 658K → 617K over 5 quarters). The Enterprise/AEM business (~30%, +8% cc ARR ex-1E churn) is the second-leg bet — TeamViewer ONE consolidating endpoint-support + DEX telemetry into the AEM category, with 620K customers and 1.4M cumulative AI sessions as proof-points. Market is pricing the SMB decline as terminal. DCF prices the Enterprise option as real but not fully de-risked. The β-pinning fix (council finding) corrects a structural mispricing: TMV's actual 5Y regression β is 0.93, but the prior run let Hamada re-lever the Damodaran Software (S&A) industry β_u of 1.33 to 2.21 — a number that bears no relationship to TMV's actual market covariance. WACC moves 7.57% → 4.79%; intrinsic moves €22.12 → €29.36.
Two debates worth pressure-testing
Why the market is at €5.47 and the DCF is at €29.36: the market is pricing a catastrophic AI-disruption bear case (terminal growth around −4% to −4.5%, Y10 margin 22-23%, zero near-term growth) as the central scenario. The DCF prices the muddle-through case — TMV converts its installed-base inertia into AEM optionality, growth fades to EUR risk-free, margin compresses gently. Even modeling negative terminal growth scenarios (scenario table: −1% terminal → €10.45/sh, −3% terminal → €7.73/sh, −5% terminal → €3.83/sh) only the severe-bear case justifies the current price. Insiders buying at €6 with personal capital, 100% free float since Sept 2025, ~23% FCF yield, and the β-pinning correction (council finding 2026-05-25) all argue the asymmetry is real. The H1 2026 print is the next data point — if Enterprise ex-1E noise reaccelerates to mid-teens cc, the bear thesis breaks.
- AI commoditization accelerates. SMB ARR already −3% cc; Copilot + Anthropic operator tools could collapse pricing power inside 3 years. Bear MC tail (P5 ≈ €13.82) covers this scenario.
- AEM fails to become a category. Enterprise growth stalls below 8% cc; 1E goodwill (~€650M+) impaired. Bull case requires mid-teens Enterprise growth not yet in the print.
- Margin floor at 20%, not 30%. Hyperscaler bundling forces Enterprise and SMB price cuts; FY26 guide 0-3% becomes the new normal, not a transition year.
- Terminal growth turns negative. Secular AI displacement makes the business a permanent revenue runoff (−3% to −5%); only the severe scenario justifies the current €5.47 price.
- FCF cliff inside explicit period. If 2027-28 revenues cliff (not just decelerate), Y1-10 PVs shrink — and the terminal value alone can't carry intrinsic.
Risks to thesis (tail, not bear case)
Bear thesis is real and unfalsifiable short-term. Microsoft Copilot + Anthropic operator tools could collapse SMB use-case pricing power inside 3 years. Bear MC tail covers this.
If 2027-28 revenue cliffs (not just decelerates), the Y1-10 PVs shrink — and the terminal value alone won't carry intrinsic. Watch H1 2026 / Q3 2026 Enterprise growth ex-1E.
~€650M+ goodwill from 1E deal; Q1 2026 saw €8M one-off churn; further deterioration triggers IFRS impairment test and reported earnings hit.
Bull thesis (DZ Bank €7) needs TeamViewer ONE / AEM to become a real category. 1.4M AI sessions and G2 #2 are early signals; not yet proven at revenue-line scale.
Microsoft Intune + Entra + Copilot collapsing the IT-ops stack threatens Enterprise mid-funnel. AEM differentiation has to be defensible, not just adjacent.
Book debt €943M (incl. IFRS-16 leases) on €165M book equity. Deleveraging on track 3.2x → 2.3x targeted, but limits flexibility for downside.
Bear-heavy (Barclays/Goldman/Bernstein at €5) vs sparse bull voices (DZ €7, RBC Buy). Mean reversion to consensus takes time and a clean print.
34% US revenue → EUR translation drag if USD weakens further. Modest given dual reporting transparency.
10-year forecast
Revenue €788M → €1.28B over 10y (5.5% Y1-5 fading to EUR risk-free 2.4% by Y10); operating margin compresses gently from 33.9% TTM to 30.00% by Y10 (AI commoditization partially offset by AEM/TeamViewer ONE switching costs).
Monte Carlo distribution
Even the bear P5 of €13.82/sh sits 153% above the market price €5.47. The MC distribution does not overlap the market price at all — P(intrinsic < market) = 0.0%. To justify the current price the joint draw on growth, margin, and terminal g would have to fall outside the 5th-95th percentile band.
1000 iterations randomising the central uncertainties (revenue growth,
op margin, terminal growth) with correlations from mc.yaml.
P(intrinsic < market €5.47) = 0.0%.
Mean €23.85 ± €6.40/sh. P5 €13.82 · P25 €18.95 · P50 €23.85 · P75 €28.23 · P95 €34.64.
Sources & cross-references
-
Country mix rationale:
valuations/tmv/country_mix_rationale.md -
Monte Carlo overlay:
valuations/tmv/mc.yaml(3 axes: growth, margin, terminal g with correlations) -
Engine result (full):
2026-05-25-result.json -
β triangulation: StockAnalysis 0.99 · SimplyWallSt 0.87 ·
Macroaxis 0.88 → pinned 0.93 via
levered_beta_override(2026-05-25 fix) - Damodaran data snapshot: ctryprem 2026-01-01 · industry_global 2026-01-01 · risk_free EUR 2024-09-01 (0.024)
Cost of capital build
| Risk-free rate | 2.40% |
| Mature-market ERP | 4.23% |
| Levered β | 0.93 |
| Weighted CRP | 0.35% |
| Cost of equity | 6.66% |
| Pre-tax cost of debt (synth A1/A+) | 3.08% |
| D / V | ~52% |
| WACC | 4.79% |
Full year-by-year DCF
| Year | Revenue | Op mgn | EBIT | EBIT(1−t) | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | €788M | 33.84% | €267M | €174M | €27M | €147M | €140M |
| 2 | €831M | 33.42% | €278M | €182M | €29M | €153M | €139M |
| 3 | €877M | 32.99% | €289M | €189M | €30M | €159M | €138M |
| 4 | €925M | 32.56% | €301M | €197M | €32M | €165M | €137M |
| 5 | €976M | 32.14% | €314M | €205M | €34M | €171M | €136M |
| 6 | €1.03B | 31.71% | €327M | €217M | €36M | €181M | €137M |
| 7 | €1.09B | 31.28% | €340M | €229M | €38M | €191M | €138M |
| 8 | €1.15B | 30.85% | €354M | €241M | €40M | €201M | €138M |
| 9 | €1.21B | 30.43% | €368M | €254M | €42M | €212M | €139M |
| 10 | €1.28B | 30.00% | €383M | €268M | €44M | €224M | €140M |
Methodology & flags
Damodaran FCFF DCF, 10y explicit + perpetuity. R&D capitalised
(3y life); IFRS-16 lease liabilities already included in book debt
(operating_leases.enabled=false to avoid double-counting).
Country-mix CRP from 14-country revenue-weighted decomposition ×
Damodaran 2026 CRPs. Levered β pinned to 0.93 via
levered_beta_override (triangulated 5Y regression) —
bypasses Hamada re-levering of the broad Software (S&A) industry
β_u which would produce ~2.21 and misprice TMV's sticky subscription
cash flows. Pre-tax cost of debt overridden to TMV's actual 4.40%
effective rate (synthetic A1/A+ would understate at 2.17%). Monte
Carlo: 1000 iterations, 3 sampled axes with correlations. Engine
v1.0.0 · result: 2026-05-25-result.json
- R&D cap: ON · Lease cap: OFF · Failure: OFF · ESO: OFF
- Sensitivity tornado: not run (MC supersedes for this valuation)
- Levered β override: 0.93 (5Y regression triangulated across StockAnalysis/SimplyWallSt/Macroaxis) vs Hamada-relevered industry β_u 1.33 → 2.21
- Pre-tax cost of debt override: 4.40% (TMV actual effective rate FY25, €40M interest / €910M financial debt) vs synthetic A1/A+ 2.17%